RANDIE MCLAUGHLIN: Open Payments
NPI 1598756389 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$332 in 12 payments from 5 companies in 2025. Trend: 2023 $247 · 2024 $45 · 2025 $332
Food & beverage: $332
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 7 | $233 |
| Endo USA, Inc. | 2 | $43 |
| Ferring Pharmaceuticals Inc. | 1 | $25 |
| UROGEN PHARMA, INC. | 1 | $16 |
| COLOPLAST CORP | 1 | $16 |
Products named: GEMTESA, AVEED, ADSTILADRIN, SpeediCath.
Industry payments across MD — which companies pay providers there.
